Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei-jun Fu

Showing results (81-90 of 83) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 83 results.
Chinese Medical Journal|July 16, 2019
Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myelomaYao Chen, Wei-Jun Fu, Lan-Ping Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2019
Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myelomaJie Xu, Li-Juan Chen, Shuang-Shuang Yang, et al.
Journal of Hematology & Oncology|July 6, 2022
Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)Wan-Hong Zhao, Bai-Yan Wang, Li-Juan Chen, et al.
Pageof 9

Showing results (81-90 of 83) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 83 results.
Chinese Medical Journal|July 16, 2019
Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myelomaYao Chen, Wei-Jun Fu, Lan-Ping Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2019
Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myelomaJie Xu, Li-Juan Chen, Shuang-Shuang Yang, et al.
Journal of Hematology & Oncology|July 6, 2022
Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)Wan-Hong Zhao, Bai-Yan Wang, Li-Juan Chen, et al.
Pageof 9